KRE, Translational Research Unit, Section of Cellular Therapy, Oslo University Hospital
Ullernchausseen 64, 0379 Oslo
Om jobben
Stillingstittel
Postdoc fellowship
Oppstart
31. oktober 2025
Type ansettelse
Engasjement, heltid 100%
Arbeidstid
Dagtid, ukedager
Arbeidsspråk
Engelsk
Antall stillinger
1
Søk senest mandag 8. september
A postdoctoral fellowship in the field of cancer immunotherapy to work on “Safety-Enhanced Chimeric Antigen Receptors (SECAR)” will be available for a period of 30 months starting from November 2025. This postdoctoral fellowship is funded by Helse Sør -Øst.
Project description
Chimeric Antigen Receptor (CAR) molecules have shown outstanding therapeutic effects for the treatment of otherwise fatal cancers; however, clinical benefits have so far only been observed in a few tumour types. The present project aims at delivering potent CAR molecules with safer profile for clinical use in cancer.
The focus lies o...